PubMed HealthSearch

PubMed · 7615026

Nitrendipine prevents the decrease caused by chronic ethanol intake in the maintenance of tetanic long-term potentiation.

Abstract

Prolonged ethanol consumption has previously been reported to decrease long-term potentiation (LTP) in isolated hippocampal slices. Dihydropyridine calcium channel antagonists, such as nitrendipine, have been previously found to prevent some of the adaptive responses to chronic ethanol intake. The present study investigated the effects of concurrent in vivo administration of nitrendipine and ethanol on LTP in isolated mouse hippocampal slices. LTP was produced by either one or two tetanic stimuli or by increased calcium. When one tetanus was used, although the potentiation of the population spike height was less after the ethanol treatment, the difference was not quite significant. However, the potentiation after in vivo administration of ethanol plus nitrendipine was significantly greater than after ethanol alone. When two tetanic stimuli were applied, the maintenance of the potentiation of the population spike height was significantly decreased by the chronic ethanol treatment. This decrease was not seen when nitrendipine was given with the ethanol. When LTP was produced by a transient increase in the calcium concentration in the bathing medium, the chronic ethanol treatment did not alter the potentiation of the population spike height, but in vivo treatment with ethanol plus nitrendipine decreased the potentiation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T L Ripley, H J Little. 1995. Nitrendipine prevents the decrease caused by chronic ethanol intake in the maintenance of tetanic long-term potentiation.. https://doi.org/10.1007/bf00241959

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit.

Excessive alcohol consumption is a major health and social issue in our society. Pharmacologic administration of the endocrine hormone fibroblast growth factor 21 (FGF21) suppresses alcohol consumption through actions in the brain in rodents, and genome-wide association studies have identified single nucleotide polymorphisms in genes involved with FGF21 signaling as being associated with increased alcohol consumption in humans. However, the neural circuit(s) through which FGF21 signals to suppress alcohol consumption are unknown, as are its effects on alcohol consumption in higher organisms. Here, we demonstrate that administration of an FGF21 analog to alcohol-preferring non-human primates reduces alcohol intake by 50%. Further, we reveal that FGF21 suppresses alcohol consumption through a projection-specific subpopulation of KLB-expressing neurons in the basolateral amygdala. Our results illustrate how FGF21 suppresses alcohol consumption through a specific population of neurons in the brain and demonstrate its therapeutic potential in non-human primate models of excessive alcohol consumption.

Alcohol Drinking